TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling

Ying Chen(Xian Mental Health Center), Mei Zhang(Anhui University of Science and Technology)

Yonsei Medical Journal

December 6, 2017

10.3349/ymj.2018.59.1.43

Cited by 29

Related Papers

miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation

|Cell Death and Disease|2017|174

Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma

|Frontiers in Oncology|2020|18

Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old

|Oncology Letters|2016|9